FONAR Co. (NASDAQ:FONR - Get Free Report) shares passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $16.05 and traded as high as $16.52. FONAR shares last traded at $16.20, with a volume of 11,476 shares changing hands.
Analyst Ratings Changes
Separately, StockNews.com lowered FONAR from a "strong-buy" rating to a "buy" rating in a report on Saturday, November 16th.
Read Our Latest Stock Report on FONR
FONAR Trading Down 1.0 %
The company has a market cap of $102.86 million, a price-to-earnings ratio of 11.61 and a beta of 1.23. The company has a fifty day moving average price of $15.49 and a two-hundred day moving average price of $16.00.
Institutional Trading of FONAR
Several institutional investors have recently modified their holdings of the company. Empowered Funds LLC grew its holdings in shares of FONAR by 5.3% during the 3rd quarter. Empowered Funds LLC now owns 18,690 shares of the medical equipment provider's stock worth $303,000 after purchasing an additional 938 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of FONAR by 148.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,012 shares of the medical equipment provider's stock worth $49,000 after buying an additional 1,799 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of FONAR by 0.6% during the 4th quarter. Dimensional Fund Advisors LP now owns 376,678 shares of the medical equipment provider's stock worth $5,703,000 after buying an additional 2,149 shares during the period. Corsair Capital Management L.P. lifted its position in shares of FONAR by 8.8% during the 3rd quarter. Corsair Capital Management L.P. now owns 27,972 shares of the medical equipment provider's stock worth $453,000 after buying an additional 2,266 shares during the period. Finally, Linden Thomas Advisory Services LLC lifted its position in shares of FONAR by 15.1% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 29,236 shares of the medical equipment provider's stock worth $443,000 after buying an additional 3,837 shares during the period. Institutional investors and hedge funds own 50.64% of the company's stock.
About FONAR
(
Get Free Report)
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Recommended Stories
Before you consider FONAR, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FONAR wasn't on the list.
While FONAR currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
